Maxcyte (MXCT) Inventory Average (2021 - 2026)

Maxcyte (MXCT) has 6 years of Inventory Average data on file, last reported at $7.6 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $7.6 million, down 11.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.6 million (down 11.69% YoY), and the FY2025 annual result was $8.2 million, down 22.14% from the prior year.
• Inventory Average was little changed at $7.6 million in Q1 2026 per MXCT's latest filing, from $7.6 million in the prior quarter.
• Over five years, Inventory Average peaked at $12.4 million in Q4 2023 and troughed at $5.9 million in Q1 2022.
• A 5-year average of $9.2 million and a median of $8.6 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2022 and 2025: Inventory Average soared 87.95% in 2022, then decreased 29.9% in 2025.
• A 5-year view of Inventory Average shows it stood at $8.2 million in 2022, then jumped by 50.14% to $12.4 million in 2023, then declined by 22.03% to $9.7 million in 2024, then retreated by 21.49% to $7.6 million in 2025, then gained by 0.13% to $7.6 million in 2026.
• Business Quant data shows MXCT's Inventory Average at $7.6 million in Q1 2026, $7.6 million in Q4 2025, and $7.8 million in Q3 2025.